Lyka Labs plans to raise Rs 100 cr via securities
Drug firm Lyka Labs has decided to raise funds up to Rs 100 crore by issue of securities.The board of directors of the company at its meeting held today has decided to raise funds up to Rs... Outcome of Board Meeting (EGM on Jan 21, 2016)
Lyka Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 28, 2015, has decided to increase Authorized Capital from existing Rs.26 crores consisting of Equity Capital of Rs.24 crores and Preference Capital of Rs. 2 crores to Rs.32 crores consisting of Equity Capital of Rs.30 crores and Preference Capital of Rs. 2 crores.... Board Meeting on Dec 28, 2015
Lyka Labs Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on December 28, 2015, to raise funds by issue of securities and take necessary action in this regard. Fixes Book Closure for AGM
Lyka Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 24, 2015 to December 30, 2015 (both days inclusive) for the purpose of 36th Annual General Meeting (AGM) of the Company to be held on December 30, 2015. Outcome of Board Meeting (Amended Insider Trading Code)
Lyka Labs Ltd has informed BSE that the Board of Directors at their meeting held on November 28, 2015 have considered Amendment in Insider Trading Code of the Company. The Amended Insider Trading Code is enclosed. Outcome of Board Meeting - Appointment of Chief Executive Officer
Lyka Labs Ltd has informed BSE that Mr. Kunal N. Gandhi holding degree of Master of Science from the University of Lancaster, U.K and presently associated with the Company as Vice President Business Development since April, 2010 has been appointed as Chief Executive Officer of the Company w.e.f January 01, 2016 by the Board of Directors at their meeting held on November 28, 2015 subject to approval of shareholders in the ensuing Annual General Meeting. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Nehal N Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Narendra I Gandhi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Shareholding Pattern as on November 02, 2015
Lyka Labs Ltd has informed BSE about the Shareholding Pattern as on November 02, 2015. Financial Results & Limited Review Report for Sept 30, 2015
Lyka Labs Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015.